Previous close | 9.30 |
Open | 9.45 |
Bid | 9.28 x 200 |
Ask | 9.37 x 100 |
Day's range | 8.97 - 9.83 |
52-week range | 1.72 - 12.88 |
Volume | |
Avg. volume | 745,457 |
Market cap | 381.079M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.70 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 13.00 |
LifeMD ( NASDAQ:LFMD ) First Quarter 2024 Results Key Financial Results Revenue: US$44.1m (up 33% from 1Q 2023). Net...
First quarter revenue increased 33% year-over-year to $44.1 million with telehealth revenue growing 53% versus the year-ago period.Raising full-year revenue guidance to at least $205 million, up from prior guidance of at least $200 million.Growth in all business segments, with weight management subscribers growing to 42,000 as of March 31, 2024. As of today, weight management subscribers exceed 50,000.Including the increase in deferred revenue from prepaid weight management subscriptions, cash-a
Key Insights Significant control over LifeMD by individual investors implies that the general public has more power to...